Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.48% | -38.73% | -0.86% | 129.46% | -0.31% |
| Total Depreciation and Amortization | -0.48% | 4.59% | -0.86% | 1.64% | 0.31% |
| Total Amortization of Deferred Charges | -0.48% | 77.82% | -0.86% | 6.18% | 0.31% |
| Total Other Non-Cash Items | -0.48% | -33.46% | -0.86% | -90.36% | 0.31% |
| Change in Net Operating Assets | 0.48% | -- | -- | -- | -0.31% |
| Cash from Operations | -0.48% | -38.03% | -0.86% | 272.38% | 0.31% |
| Capital Expenditure | 0.48% | -- | -- | -- | -0.31% |
| Sale of Property, Plant, and Equipment | -0.48% | -- | -- | -- | 0.31% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -0.48% | -- | -- | -- | 0.31% |
| Other Investing Activities | 0.48% | 5.54% | 0.86% | -899.39% | 0.31% |
| Cash from Investing | 0.48% | -63.10% | 0.86% | -52.96% | -0.31% |
| Total Debt Issued | 0.00% | -74.23% | 0.00% | 67.19% | 0.00% |
| Total Debt Repaid | 0.00% | 76.05% | 0.00% | -231.25% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00% | 28.75% | 0.00% | -67.36% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.48% | -- | -- | -- | -0.31% |
| Other Financing Activities | 0.00% | -96.92% | 0.00% | 4,533.51% | 0.00% |
| Cash from Financing | 0.48% | -344.98% | -0.86% | 170.20% | -0.31% |
| Foreign Exchange rate Adjustments | -0.51% | 189.24% | -0.73% | -67.69% | 0.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.48% | -209.83% | -0.86% | 270.95% | -0.31% |